Scott, David A <br/><br/>
Evidence that CB-1 and CB-2 cannabinoid receptors mediate antinociception in neuropathic pain in the rat.  [electronic resource] 

 -  Pain  May 2004 
 - 124-31 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>0304-3959 
<br/><br/><label>Standard No.: </label>10.1016/j.pain.2004.01.020  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Analgesics--pharmacology<br/>Analysis of Variance<br/>Animals<br/>Behavior, Animal--drug effects<br/>Camphanes--pharmacology<br/>Cyclohexanols--pharmacology<br/>Dose-Response Relationship, Drug<br/>Drug Administration Routes<br/>Drug Interactions<br/>Ligation--methods<br/>Male<br/>Nociceptors--drug effects<br/>Pain--physiopathology<br/>Pain Measurement--drug effects<br/>Piperidines--pharmacology<br/>Pyrazoles--pharmacology<br/>Rats<br/>Rats, Sprague-Dawley<br/>Reaction Time<br/>Receptor, Cannabinoid, CB1--antagonists & inhibitors<br/>Receptor, Cannabinoid, CB2--antagonists & inhibitors<br/>Rimonabant<br/>Spinal Nerves--injuries<br/>Time Factors